Logo image of PRLB

PROTO LABS INC (PRLB) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:PRLB - US7437131094 - Common Stock

52.5 USD
-0.07 (-0.13%)
Last: 12/15/2025, 12:21:00 PM
Fundamental Rating

4

Taking everything into account, PRLB scores 4 out of 10 in our fundamental rating. PRLB was compared to 130 industry peers in the Machinery industry. PRLB has a great financial health rating, but its profitability evaluates not so good. PRLB is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

PRLB had positive earnings in the past year.
In the past year PRLB had a positive cash flow from operations.
Of the past 5 years PRLB 4 years were profitable.
In the past 5 years PRLB always reported a positive cash flow from operatings.
PRLB Yearly Net Income VS EBIT VS OCF VS FCFPRLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

With a Return On Assets value of 1.96%, PRLB perfoms like the industry average, outperforming 42.31% of the companies in the same industry.
PRLB has a Return On Equity of 2.23%. This is in the lower half of the industry: PRLB underperforms 62.31% of its industry peers.
PRLB's Return On Invested Capital of 2.11% is on the low side compared to the rest of the industry. PRLB is outperformed by 67.69% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PRLB is significantly below the industry average of 10.30%.
Industry RankSector Rank
ROA 1.96%
ROE 2.23%
ROIC 2.11%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
PRLB Yearly ROA, ROE, ROICPRLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

PRLB has a Profit Margin (2.86%) which is in line with its industry peers.
PRLB's Profit Margin has declined in the last couple of years.
PRLB has a worse Operating Margin (4.35%) than 63.85% of its industry peers.
In the last couple of years the Operating Margin of PRLB has declined.
PRLB has a better Gross Margin (44.12%) than 82.31% of its industry peers.
In the last couple of years the Gross Margin of PRLB has declined.
Industry RankSector Rank
OM 4.35%
PM (TTM) 2.86%
GM 44.12%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
PRLB Yearly Profit, Operating, Gross MarginsPRLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PRLB is destroying value.
The number of shares outstanding for PRLB has been reduced compared to 1 year ago.
Compared to 5 years ago, PRLB has less shares outstanding
Compared to 1 year ago, PRLB has an improved debt to assets ratio.
PRLB Yearly Shares OutstandingPRLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRLB Yearly Total Debt VS Total AssetsPRLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

PRLB has an Altman-Z score of 9.58. This indicates that PRLB is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 9.58, PRLB belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
There is no outstanding debt for PRLB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 9.58
ROIC/WACC0.22
WACC9.67%
PRLB Yearly LT Debt VS Equity VS FCFPRLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 3.24 indicates that PRLB has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.24, PRLB is doing good in the industry, outperforming 80.00% of the companies in the same industry.
PRLB has a Quick Ratio of 3.04. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
PRLB has a better Quick ratio (3.04) than 87.69% of its industry peers.
Industry RankSector Rank
Current Ratio 3.24
Quick Ratio 3.04
PRLB Yearly Current Assets VS Current LiabilitesPRLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

The earnings per share for PRLB have decreased by -7.02% in the last year.
PRLB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.19% yearly.
The Revenue has been growing slightly by 2.82% in the past year.
The Revenue has been growing slightly by 1.78% on average over the past years.
EPS 1Y (TTM)-7.02%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%0%
Revenue 1Y (TTM)2.82%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%7.76%

3.2 Future

PRLB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.49% yearly.
Based on estimates for the next years, PRLB will show a small growth in Revenue. The Revenue will grow by 5.30% on average per year.
EPS Next Y-2.34%
EPS Next 2Y1.89%
EPS Next 3Y6.49%
EPS Next 5YN/A
Revenue Next Year5.31%
Revenue Next 2Y5.09%
Revenue Next 3Y5.3%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PRLB Yearly Revenue VS EstimatesPRLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
PRLB Yearly EPS VS EstimatesPRLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 33.02, which means the current valuation is very expensive for PRLB.
62.31% of the companies in the same industry are cheaper than PRLB, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.56, PRLB is valued a bit more expensive.
With a Price/Forward Earnings ratio of 31.03, PRLB can be considered very expensive at the moment.
64.62% of the companies in the same industry are cheaper than PRLB, based on the Price/Forward Earnings ratio.
PRLB is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.02
Fwd PE 31.03
PRLB Price Earnings VS Forward Price EarningsPRLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

63.08% of the companies in the same industry are cheaper than PRLB, based on the Enterprise Value to EBITDA ratio.
PRLB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PRLB is cheaper than 74.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.36
EV/EBITDA 19.47
PRLB Per share dataPRLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.89%
EPS Next 3Y6.49%

0

5. Dividend

5.1 Amount

No dividends for PRLB!.
Industry RankSector Rank
Dividend Yield 0%

PROTO LABS INC

NYSE:PRLB (12/15/2025, 12:21:00 PM)

52.5

-0.07 (-0.13%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-31 2025-10-31/bmo
Earnings (Next)02-05 2026-02-05/bmo
Inst Owners93.57%
Inst Owner Change1.31%
Ins Owners1.08%
Ins Owner Change0.28%
Market Cap1.24B
Revenue(TTM)518.38M
Net Income(TTM)14.84M
Analysts78.18
Price Target57.8 (10.1%)
Short Float %3.01%
Short Ratio3.48
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.68%
Min EPS beat(2)17.55%
Max EPS beat(2)17.81%
EPS beat(4)4
Avg EPS beat(4)15.66%
Min EPS beat(4)10.87%
Max EPS beat(4)17.81%
EPS beat(8)8
Avg EPS beat(8)23.41%
EPS beat(12)12
Avg EPS beat(12)26.01%
EPS beat(16)15
Avg EPS beat(16)25.13%
Revenue beat(2)1
Avg Revenue beat(2)1.29%
Min Revenue beat(2)-0.84%
Max Revenue beat(2)3.41%
Revenue beat(4)2
Avg Revenue beat(4)0.49%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)3.41%
Revenue beat(8)4
Avg Revenue beat(8)0.18%
Revenue beat(12)7
Avg Revenue beat(12)0.91%
Revenue beat(16)8
Avg Revenue beat(16)0.39%
PT rev (1m)13.33%
PT rev (3m)13.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.37%
EPS NY rev (1m)2.23%
EPS NY rev (3m)7.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 33.02
Fwd PE 31.03
P/S 2.4
P/FCF 18.36
P/OCF 16.5
P/B 1.87
P/tB 3.35
EV/EBITDA 19.47
EPS(TTM)1.59
EY3.03%
EPS(NY)1.69
Fwd EY3.22%
FCF(TTM)2.86
FCFY5.45%
OCF(TTM)3.18
OCFY6.06%
SpS21.89
BVpS28.07
TBVpS15.68
PEG (NY)N/A
PEG (5Y)N/A
Graham Number31.69
Profitability
Industry RankSector Rank
ROA 1.96%
ROE 2.23%
ROCE 3.28%
ROIC 2.11%
ROICexc 2.56%
ROICexgc 5.3%
OM 4.35%
PM (TTM) 2.86%
GM 44.12%
FCFM 13.06%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
ROICexc(3y)2.8%
ROICexc(5y)3.78%
ROICexgc(3y)5.45%
ROICexgc(5y)6.71%
ROCE(3y)3.77%
ROCE(5y)4.91%
ROICexgc growth 3Y-8.13%
ROICexgc growth 5Y-18.97%
ROICexc growth 3Y-4.98%
ROICexc growth 5Y-24.03%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 22.08%
Cap/Sales 1.47%
Interest Coverage 250
Cash Conversion 132.03%
Profit Quality 456.43%
Current Ratio 3.24
Quick Ratio 3.04
Altman-Z 9.58
F-Score6
WACC9.67%
ROIC/WACC0.22
Cap/Depr(3y)51.87%
Cap/Depr(5y)76.84%
Cap/Sales(3y)3.95%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.02%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%0%
EPS Next Y-2.34%
EPS Next 2Y1.89%
EPS Next 3Y6.49%
EPS Next 5YN/A
Revenue 1Y (TTM)2.82%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%7.76%
Revenue Next Year5.31%
Revenue Next 2Y5.09%
Revenue Next 3Y5.3%
Revenue Next 5YN/A
EBIT growth 1Y-24.4%
EBIT growth 3Y-14.15%
EBIT growth 5Y-20.42%
EBIT Next Year63.4%
EBIT Next 3Y26.27%
EBIT Next 5YN/A
FCF growth 1Y32.02%
FCF growth 3Y48.42%
FCF growth 5Y4.96%
OCF growth 1Y13.3%
OCF growth 3Y12.13%
OCF growth 5Y-7.69%

PROTO LABS INC / PRLB FAQ

Can you provide the ChartMill fundamental rating for PROTO LABS INC?

ChartMill assigns a fundamental rating of 4 / 10 to PRLB.


What is the valuation status for PRLB stock?

ChartMill assigns a valuation rating of 1 / 10 to PROTO LABS INC (PRLB). This can be considered as Overvalued.


How profitable is PROTO LABS INC (PRLB) stock?

PROTO LABS INC (PRLB) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for PRLB stock?

The Price/Earnings (PE) ratio for PROTO LABS INC (PRLB) is 33.02 and the Price/Book (PB) ratio is 1.87.


What is the earnings growth outlook for PROTO LABS INC?

The Earnings per Share (EPS) of PROTO LABS INC (PRLB) is expected to decline by -2.34% in the next year.